Self-Care Practices with Psychedelics – A Qualitative Study of Users’ Perspectives

References

• Bardin, L. 1977. Análise de Conteúdo, 70. Lisboa: Edições.
   Google Scholar
• Barone, W., J. Beck, M. Mitsunaga-Whitten, and P. Perl. 2019. Perceived benefits of MDMA-assisted psychotherapy beyond symptom reduction: Qualitative follow-up study of a clinical trial for individuals with treatment-resistant PTSD. Journal of Psychoactive Drugs 51(2):199–208. Advance online publication. doi:10.1080/02791072.2019.1580805.
   PubMed Web of Science ®Google Scholar
• Belser, A. B., G. Agin-Liebes, T. C. Swift, S. Terrana, N. Devenot, H. L. Friedman, J. Guss, A. Bossis, and S. Ross. 2017. Patient experiences of psilocybin-assisted psychotherapy: An interpretative phenomenological analysis. Journal of Humanistic Psychology 57 (4):354–88. doi:10.1177/0022167817706884.
   Web of Science ®Google Scholar
• Bogenschutz, M. P., A. A. Forcehimes, J. A. Pommy, C. E. Wilcox, P. C. R. Barbosa, and R. J. Strassman. 2015. Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study. Journal of Psychopharmacology 29 (3):289–99. doi:10.1177/0269881114565144.
   PubMed Web of Science ®Google Scholar
• Breeksema, J. J., A. R. Niemeijer, E. Krediet, E. Vermetten, and R. A. Schoevers. 2020. Psychedelic treatments for psychiatric disorders: A systematic review and thematic synthesis of patient experiences in qualitative studies. CNS Drugs 34 (9):925–46. doi:10.1007/s40263-020-00748-y.
   PubMed Web of Science ®Google Scholar
• Brouwer A and Carhart-Harris R Lester. (2021). Pivotal mental states. J Psychopharmacol, 35(4), 319–352. 10.1177/0269881120959637
   PubMed Web of Science ®Google Scholar
• Butler, L. D., K. A. Mercer, K. McClain-Meeder, D. M. Horne, and M. Dudley. 2019. Six domains of self-care: Attending to the whole person. Journal of Human Behavior in the Social Environment 29(1):107–24. Retrieved from. doi:10.1080/10911359.2018.1482483.
   Web of Science ®Google Scholar
• Carbonaro, T. M., M. P. Bradstreet, F. S. Barret, K. A. MacLean, R. Jesse, M. W. Johnson, and R. R. Griffiths. 2016. Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. Journal of Psychopharmacology (Oxford, England) 30 (12):1268–78. doi:10.1177/0269881116662634.
   PubMed Web of Science ®Google Scholar
• Carhart-Harris, R. L., M. Bolstridge, J. Rucker, C. M. J. Day, D. Erritzoe, M. Kaelen, M. Bloomfield, J. A. Richard, B. Forbes, A. Feilding, et al. 2016. Psilocybin with psychological support for treatment-resistant depression: An open-label feasibility study. The Lancet Psychiatry 3 (7):619–27. doi:10.1016/S2215-0366(16)30065-7.
   PubMed Web of Science ®Google Scholar
• Carhart-Harris, R. L., L. Roseman, E. Haijen, D. Erritzoe, R. Watts, I. Branchi, and M. Kaelen. 2018. Psychedelics and the essential importance of context. Journal of Psychopharmacology 32 (7):1–7. doi:10.1177/0269881118754710.
   Web of Science ®Google Scholar
• Carvalho, M. C., M. P. Sousa, P. Frango, P. Dias, J. Carvalho, and M. Rodrigues. 2014. Crisis intervention related to the use of psychoactive substances in recreational settings - Evaluating the kosmicare project at boom festival. Current Drug Abuse Reviews 7 (2):81–100. doi:10.2174/1874473708666150107115515.
   PubMedGoogle Scholar
• Creswell, J. W. 1998. Qualitative inquiry and research design: Choosing among five traditions. London: Sage Publications.
   Google Scholar
• Danforth, A. L., C. S. Grob, C. Struble, A. A. Feduccia, N. Walker, L. Jerome, B. Yazar-Klosinski, and A. Emerson. 2018. Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: A randomized, double-blind, placebo-controlled pilot study. Psychopharmacology 235 (11):3137–48. doi:10.1007/s00213-018-5010-9.
   PubMed Web of Science ®Google Scholar
• Denyes, M. J., D. E. Orem, and G. B. SozWiss. 2001. Self-Care: A foundational science. Nursing Science Quarterly 14 (1):48–54. doi:10.1177/089431840101400113.
   PubMed Web of Science ®Google Scholar
• Dorociak, K. E., P. A. Rupert, F. B. Bryant, and E. Zahniser. 2017. Development of a self-care assessment for psychologists. Journal of Counseling Psychology 64 (3):325–34. doi:10.1037/cou0000206.
   PubMed Web of Science ®Google Scholar
• Frescka, E., P. Bokor, and M. Winkelman. 2016. The therapeutic potentials of ayahuasca: Possible effects against various diseases of civilization. Frontiers in Pharmacology 35. doi:10.3389/fphar.2016.00035.
   Web of Science ®Google Scholar
• Gasser, P., D. Holstein, Y. Michel, R. Doblin, B. Yazar-Klosinski, T. Passie, and R. Brenneisen. 2014. Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases. Journal of Nervous and Mental Disease 202 (7):513–20. doi:10.1097/NMD.0000000000000113.
   PubMed Web of Science ®Google Scholar
• Godfrey, C. M. 2011. Self-care: A clarification of meaning and examination of supportive strategies. Dissertation Abstracts International: Section B. The Sciences and Engineering, 72(4-B) 2067.
   Google Scholar
• Griffiths, R. R., M. W. Johnson, M. A. Carducci, A. Umbricht, W. A. Richards, B. D. Richards, M. P. Cosimano, and M. A. Klinedinst. 2016. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology 30 (12):1181–97. doi:10.1177/0269881116675513.
   PubMed Web of Science ®Google Scholar
• Hartogsohn I. (2016). Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology. J Psychopharmacol, 30(12), 1259–1267. 10.1177/0269881116677852
   PubMed Web of Science ®Google Scholar
• Johnson, M. W., A. Garcia-Romeu, M. P. Cosimano, and R. R. Griffiths. 2014. Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction. Journal of Psychopharmacology 28 (11):983–92. doi:10.1177/0269881114548296.
   PubMed Web of Science ®Google Scholar
• Johnstad, P. G. 2015. User perceptions of mental health consequences of hallucinogen use in self-identified spiritual contexts. Nordic Studies on Alcohol and Drugs 32 (6):545–62. doi:10.1515/nsad-2015-0053.
   Web of Science ®Google Scholar
• Kavenská, V., and H. Simonová. 2015. Ayahuasca tourism: Participants in shamanic rituals and their personality styles, motivation, benefits and risks. Journal of Psychoactive Drugs 47 (5):351–59. doi:10.1080/02791072.2015.1094590.
   PubMed Web of Science ®Google Scholar
• Krupitsky, E. M., A. M. Burakov, I. V. Dunaevsky, T. N. Romanova, T. Y. Slavina, and A. Y. Grinenko. 2007. Single versus repeated sessions of ketamine-assisted psychotherapy for people with heroin dependence. Journal of Psychoactive Drugs 39 (1):13–19. doi:10.1080/02791072.2007.10399860.
   PubMed Web of Science ®Google Scholar
• Loizaga-Velder, A., and R. Verres. 2014. Therapeutic effects of ritual ayahuasca use in the treatment of substance dependence – Qualitative results. Journal of Psychoactive Drugs 46 (1):63–72. doi:10.1080/02791072.2013.873157.
   PubMed Web of Science ®Google Scholar
• Maia, L. O., D. Daldegan-Bueno, and L. F. Tófoli. 2020. The ritual use of ayahuasca during treatment of severe physical illnesses: A qualitative study. Journal of Psychoactive Drugs 53 (3):272–82. doi:10.1080/02791072.2020.1854399.
   PubMed Web of Science ®Google Scholar
• Mason, N. L., D. C. Dolder, and K. P. C. Kuypers. 2020. Reported effects of psychedelic use on those with low well-being given various emotional states and social contexts. Drug Science, Policy and Law 6:1–11. doi:10.1177/2050324519900068.
   Google Scholar
• Masters, R. A. 2010. Spiritual bypassing – when spirituality disconnects us from what really matters. California: North Atlantic Books.
   Google Scholar
• Merleau-Ponty, M. 1945. Phénoménologie de la Perception. Gallimard: France.
   Google Scholar
• Mitchell, J. M., M. Bogenschutz, A. Lilienstein, C. Harrison, S. Kleiman, K. Parker-Guilbert, M. Ot’alora G, W. Garas, C. Paleos, I. Gorman, et al. 2021. MDMA-assisted therapy for severe PTSD: A randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine 27 (6):1025–33. doi:10.1038/s41591-021-01336-3.
   PubMed Web of Science ®Google Scholar
• Moreno, F. A., C. B. Wiegand, E. K. Taitano, and P. L. Delgado. 2006. Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. The Journal of Clinical Psychiatry 67 (11):1735–40. doi:10.4088/JCP.v67n1110.
   PubMed Web of Science ®Google Scholar
• Morin, A. 2017. Toward a glossary of self-related terms. Frontiers in Psychology 8:1–9. doi:10.3389/fpsyg.2017.00280.
   PubMed Web of Science ®Google Scholar
• Noorani, T., A. Garcia-Romeu, T. C. Swift, R. R. Griffiths, and M. W. Johnson. 2018. Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts. Journal of Psychopharmacology 32 (7):756–69. doi:10.1177/0269881118780612.
   PubMed Web of Science ®Google Scholar
• Palhano-Fontes, F., D. Barreto, H. Onias, K. C. Andrade, M. M. Novaes, J. A. Pessoa, and D. B. Araújo. 2018. Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression A randomized placebo-controlled trial. Psychological Medicine 49(4):655–63. Advance online publication. doi:10.1017/S0033291718001356.
   PubMed Web of Science ®Google Scholar
• Pargament, K. I. 2007. Spirituality integrated psychotherapy – understanding and addressing the sacred. London: The Guilford Press.
   Google Scholar
• Ritchie, J., and J. Lewis, Eds. 2003. Qualitative research practice - a guide for social science students and researchers. London: SAGE Publications.
   Google Scholar
• Ross, S., A. Bossis, J. Guss, G. Agin-Liebes, T. Malone, B. Cohen, S. E. Mennenga, A. Belser, K. Kalliontzi, J. Babb, et al. 2016. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: A randomized controlled trial. Journal of Psychopharmacology 30 (12):1165–80. doi:10.1177/0269881116675512.
   PubMed Web of Science ®Google Scholar
• Rupert, P. A., and K. E. Dorociak. 2019. Self-care, stress, and well-being among practicing psychologists. Professional Psychology, Research and Practice 50(5):343–50. Advance online publication. doi:10.1037/pro0000251.
   Web of Science ®Google Scholar
• Sessa, B. 2012. The psychedelic renaissance: Reassessing the role of psychedelic drugs in 21st century psychiatry and society. London: Muswell Hill Press.
   Google Scholar
• Soderhamn, O. 2000. Self-care activity as a structure: A phenomenological approach. Scandinavian Journal of Occupational Therapy 7 (4):183–89. doi:10.1080/110381200300008724.
   Google Scholar
• Swift, T. C., A. B. Belser, G. Agin-Liebes, N. Devenot, S. Terrana, H. L. Friedman, J. Guss, A. Bossis, and S. Ross. 2017. Cancer at the dinner table: Experiences of psilocybin-assisted psychotherapy for the treatment of cancer-related distress. Journal of Humanistic Psychology 57 (5):488–519. doi:10.1177/0022167817715966.
   Web of Science ®Google Scholar
• Tong, A., P. Sainsbury, and J. Craig. 2007. Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. International Journal for Quality in Health Care 19 (6):349–57. doi:10.1093/intqhc/mzm042.
   PubMed Web of Science ®Google Scholar
• Watts, R., C. Day, J. Krzanowski, D. Nutt, and R. Carhart-Harris. 2017. Patients’ accounts of increased “connectedness” and “acceptance” after psilocybin for treatment-resistant depression. Journal of Humanistic Psychology 57 (5):520–64. doi:10.1177/0022167817709585.
   Web of Science ®Google Scholar
• Willig, C., Ed. 2013. Introducing qualitative research in psychology. USA: Open University Press.
   Google Scholar
• Winkelman M. (2005). Drug Tourism or Spiritual Healing? Ayahuasca Seekers in Amazonia. Journal of Psychoactive Drugs, 37(2), 209–218. 10.1080/02791072.2005.10399803
   PubMed Web of Science ®Google Scholar
• Zarate, C. A., Jr., J. Singh, P. J. Carlson, N. E. Brutsche, R. Ameli, D. A. Luckenbaugh, and H. Manji. 2006. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Archives of General Psychiatry 63 (8):856–64. doi:10.1001/archpsyc.63.8.856.
   PubMed Web of Science ®Google Scholar